Subcutaneous Alemtuzumab Combined With Oral Dexamethasone, Followed by Alemtuzumab Maintenance or Allo-SCT in CLL With 17p- or Refractory to Fludarabine
Clinical trial NCT01392079 · COMPLETED
Trial details
- NCT number
- NCT01392079
- Sponsor
- University of Ulm
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-02-01
- Primary completion
- 2012-01-01
- Enrollment
- 135
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.